Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Virpax Pharmaceuticals, Inc. (VRPX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| Gudin Jeffrey (Chief Medical Officer) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.788, valued at
$39.4k
|
|
| 01/27/2023 |
4
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $0.788, valued at
$98.5k
|
|
| 01/27/2023 |
4
| Chipman Christopher Michael (CFO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 112,000 options to buy
@ $0.788, valued at
$88.3k
|
|
| 01/04/2023 |
4
| Jambulingam Thani (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.622, valued at
$24.9k
|
|
| 01/04/2023 |
4
| Floyd Eric (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 45,000 options to buy
@ $0.622, valued at
$28k
|
|
| 01/04/2023 |
4
| Sendrow Jerrold (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options to buy
@ $0.622, valued at
$21.8k
|
|
| 01/04/2023 |
4
| Dubin Michael F (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.622, valued at
$12.4k
|
|
| 01/04/2023 |
4
| Singh Vanila (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.622, valued at
$9.3k
|
|
| 05/26/2022 |
4
| Sendrow Jerrold (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 4,500 shares
@ $1.29, valued at
$5.8k
|
|
| 05/20/2022 |
4
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 75,750 shares
@ $1.34, valued at
$101.5k
|
|
| 05/20/2022 |
4
| Floyd Eric (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 4,479 shares
@ $1.3635, valued at
$6.1k
|
|
| 04/27/2022 |
4
| Bruce Gerald W (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $1.76, valued at
$105.6k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Sendrow Jerrold (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 12,091 options to buy
@ $3.43, valued at
$41.5k
|
|
| 01/05/2022 |
4
| Jambulingam Thani (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 14,113 options to buy
@ $3.43, valued at
$48.4k
|
|
| 01/05/2022 |
4
| Singh Vanila (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 12,091 options to buy
@ $3.43, valued at
$41.5k
|
|
| 01/05/2022 |
4
| Dubin Michael F (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 12,091 options to buy
@ $3.43, valued at
$41.5k
|
|
| 01/05/2022 |
4
| Floyd Eric (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 15,124 options to buy
@ $3.43, valued at
$51.9k
|
|
| 01/05/2022 |
4
| JACOB GARY S (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 12,091 options to buy
@ $3.43, valued at
$41.5k
|
|
| 11/24/2021 |
4
| Sendrow Jerrold (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 3,900 shares
@ $3.925, valued at
$15.3k
|
|
| 11/22/2021 |
4
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 25,125 shares
@ $3.99, valued at
$100.2k
|
|
| 08/05/2021 |
4
| Dubin Michael F (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 20,225 options to buy
@ $4.32, valued at
$87.4k
|
|
| 04/09/2021 |
4
| Gudin Jeffrey (Chief Medical Officer) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.62, valued at
$231k
|
|
| 04/09/2021 |
4
| Singh Vanila (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 8,183 options to buy
@ $4.62, valued at
$37.8k
|
|
| 04/09/2021 |
4
| Jambulingam Thani (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 10,205 options to buy
@ $4.62, valued at
$47.1k
|
|
| 04/09/2021 |
4
| Sendrow Jerrold (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 10,205 options to buy
@ $4.62, valued at
$47.1k
|
|
| 04/09/2021 |
4
| Bruce Gerald W (EVP, Commercial Operations) has filed a Form 4 on Virpax Pharmaceuticals, Inc. |
| 04/09/2021 |
4
| Floyd Eric (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 11,216 options to buy
@ $4.62, valued at
$51.8k
|
|
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2021 |
4
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.62, valued at
$231k
|
|
|
|
|